Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Antibiotic | Research

Blood stream Infections in chronic hemodialysis patients - characteristics and outcomes

Authors: Miri Schamroth Pravda, Yasmin Maor, Konstantin Brodsky, Anna Katkov, Relu Cernes, Nili Schamroth Pravda, Milena Tocut, Iris Zohar, Arie Soroksky, Leonid Feldman

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Introduction

Bloodstream Infections (BSI) are a major cause of death and hospitalization among hemodialysis (HD) patients. The rates of BSI among HD patients vary and are influenced by local patient and pathogen characteristics. Modifications in local infection prevention protocols in light of active surveillance of BSI has been shown to improve clinical outcomes. The aim of this study was to further explore factors associated with BSI in a contemporary cohort of HD patients at a public teaching hospital dialysis center in Israel.

Methods

This was a retrospective cohort study of HD patients with a BSI in the years 2014 to 2018. The primary outcome was the occurrence of BSI. Secondary outcomes were to describe the causative pathogens of BSI, and to assess for risk factors for BSI, and mortality.

Results

Included were 251 patients. The mean age was 68.5 ± 13.4 years, 66.9% were male. The mean time from initiation of dialysis was 34.76 ± 40.77 months, interquartile range (IQR) 1-47.5 months and the follow up period of the cohort was 25.17 ± 15.9 months. During the observation period, 44 patients (17.5%) developed 54 BSI events, while 10 of them (3.9% of the whole cohort) developed recurrent BSI events. Gram-negative microorganisms caused 46.3% of all BSI events. 31.4% of these BSI were caused by resistant bacteria. In a multivariate logistic regression analysis, patients receiving dialysis through a central line had a significantly increased risk for BSI adjusted Odds Ratio (aOR) 3.907, p = 0.005, whereas patients’ weight was mildly protective (aOR 0.971, p = 0.024).

Conclusions

We noted an increased prevalence of gram-negative pathogens in the etiology of BSI in HD patients. Based on our findings, additional empirical antibiotics addressing gram negative bacteria have been added to our empirical treatment protocol. Our findings highlight the need to follow local epidemiology for implementing appropriate preventative measures and for tailoring appropriate empiric antibiotic therapy.
Literature
1.
go back to reference Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, et al. US renal data system 2019 annual data report: epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2020;75(1 Suppl 1):A6–7.CrossRefPubMed Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, et al. US renal data system 2019 annual data report: epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2020;75(1 Suppl 1):A6–7.CrossRefPubMed
2.
go back to reference Dalrymple LS, Johansen KL, Chertow GM, Cheng S-C, Grimes B, Gold EB, et al. Infection-related hospitalizations in older patients with ESRD. Am J Kidney Dis. 2010;56(3):522–30.CrossRefPubMedPubMedCentral Dalrymple LS, Johansen KL, Chertow GM, Cheng S-C, Grimes B, Gold EB, et al. Infection-related hospitalizations in older patients with ESRD. Am J Kidney Dis. 2010;56(3):522–30.CrossRefPubMedPubMedCentral
3.
go back to reference Dalrymple LS, Mu Y, Romano PS, Nguyen DV, Chertow GM, Delgado C, et al. Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis. Am J Kidney Dis. 2015;65(5):754–62.CrossRefPubMedPubMedCentral Dalrymple LS, Mu Y, Romano PS, Nguyen DV, Chertow GM, Delgado C, et al. Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis. Am J Kidney Dis. 2015;65(5):754–62.CrossRefPubMedPubMedCentral
4.
go back to reference Locham S, Naazie I, Canner J, Siracuse J, Al-Nouri O, Malas M. Incidence and risk factors of sepsis in hemodialysis patients in the United States. J Vasc Surg. 2021;73(3):1016–1021e3.CrossRefPubMed Locham S, Naazie I, Canner J, Siracuse J, Al-Nouri O, Malas M. Incidence and risk factors of sepsis in hemodialysis patients in the United States. J Vasc Surg. 2021;73(3):1016–1021e3.CrossRefPubMed
5.
go back to reference Shima H, Okamoto T, Tashiro M, Inoue T, Masaki C, Tanaka Y, et al. Clinical characteristics and risk factors for mortality due to Bloodstream Infection of Unknown Origin in Hemodialysis patients: a Single-Center, Retrospective Study. Blood Purif. 2021;50(2):238–45.CrossRefPubMed Shima H, Okamoto T, Tashiro M, Inoue T, Masaki C, Tanaka Y, et al. Clinical characteristics and risk factors for mortality due to Bloodstream Infection of Unknown Origin in Hemodialysis patients: a Single-Center, Retrospective Study. Blood Purif. 2021;50(2):238–45.CrossRefPubMed
6.
go back to reference AbuTaha SA, Al-Kharraz T, Belkebir S, Abu Taha A, Zyoud SH. Patterns of microbial resistance in bloodstream Infections of hemodialysis patients: a cross-sectional study from Palestine. Sci Rep. 2022;12(1):18003.CrossRefPubMedPubMedCentral AbuTaha SA, Al-Kharraz T, Belkebir S, Abu Taha A, Zyoud SH. Patterns of microbial resistance in bloodstream Infections of hemodialysis patients: a cross-sectional study from Palestine. Sci Rep. 2022;12(1):18003.CrossRefPubMedPubMedCentral
7.
go back to reference Fram D, Okuno MFP, Taminato M, Ponzio V, Manfredi SR, Grothe C, et al. Risk factors for bloodstream Infection in patients at a Brazilian hemodialysis center: a case-control study. BMC Infect Dis. 2015;15:158.CrossRefPubMedPubMedCentral Fram D, Okuno MFP, Taminato M, Ponzio V, Manfredi SR, Grothe C, et al. Risk factors for bloodstream Infection in patients at a Brazilian hemodialysis center: a case-control study. BMC Infect Dis. 2015;15:158.CrossRefPubMedPubMedCentral
8.
go back to reference Skov Dalgaard L, Nørgaard M, Jespersen B, Jensen-Fangel S, Østergaard LJ, Schønheyder HC, et al. Risk and prognosis of Bloodstream Infections among patients on chronic hemodialysis: a Population-based Cohort Study. PLoS ONE. 2015;10(4):e0124547.CrossRefPubMedPubMedCentral Skov Dalgaard L, Nørgaard M, Jespersen B, Jensen-Fangel S, Østergaard LJ, Schønheyder HC, et al. Risk and prognosis of Bloodstream Infections among patients on chronic hemodialysis: a Population-based Cohort Study. PLoS ONE. 2015;10(4):e0124547.CrossRefPubMedPubMedCentral
9.
go back to reference Rteil A, Kazma JM, El Sawda J, Gharamti A, Koubar SH, Kanafani ZA. Clinical characteristics, risk factors and microbiology of Infections in patients receiving chronic hemodialysis. J Infect Public Health. 2020;13(8):1166–71.CrossRefPubMed Rteil A, Kazma JM, El Sawda J, Gharamti A, Koubar SH, Kanafani ZA. Clinical characteristics, risk factors and microbiology of Infections in patients receiving chronic hemodialysis. J Infect Public Health. 2020;13(8):1166–71.CrossRefPubMed
10.
go back to reference Rosenblum A, Wang W, Ball LK, Latham C, Maddux FW, Lacson E. Hemodialysis catheter care strategies: a cluster-randomized quality improvement initiative. Am J Kidney Dis. 2014;63(2):259–67.CrossRefPubMed Rosenblum A, Wang W, Ball LK, Latham C, Maddux FW, Lacson E. Hemodialysis catheter care strategies: a cluster-randomized quality improvement initiative. Am J Kidney Dis. 2014;63(2):259–67.CrossRefPubMed
11.
go back to reference Wetmore JB, Li S, Molony JT, Guo H, Herzog CA, Gilbertson DT, et al. Insights from the 2016 peer kidney care initiative report: still a ways to go to improve care for dialysis patients. Am J Kidney Dis. 2018;71(1):123–32.CrossRefPubMed Wetmore JB, Li S, Molony JT, Guo H, Herzog CA, Gilbertson DT, et al. Insights from the 2016 peer kidney care initiative report: still a ways to go to improve care for dialysis patients. Am J Kidney Dis. 2018;71(1):123–32.CrossRefPubMed
12.
go back to reference Mohamed H, Ali A, Browne LD, O’Connell NH, Casserly L, Stack AG, et al. Determinants and outcomes of access-related blood-stream Infections among Irish haemodialysis patients; a cohort study. BMC Nephrol. 2019;20(1):68.CrossRefPubMedPubMedCentral Mohamed H, Ali A, Browne LD, O’Connell NH, Casserly L, Stack AG, et al. Determinants and outcomes of access-related blood-stream Infections among Irish haemodialysis patients; a cohort study. BMC Nephrol. 2019;20(1):68.CrossRefPubMedPubMedCentral
14.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81.CrossRefPubMed
15.
go back to reference Lee K-G, Ng LC, Yeon W, Silva Thore S, Rahman MA, Rofi SNM, et al. Reducing tunneled catheter-related Infection in hemodialysis patients with nationwide standardization of catheter care protocol. J Vasc Access. 2018;19(1):110–1.CrossRefPubMed Lee K-G, Ng LC, Yeon W, Silva Thore S, Rahman MA, Rofi SNM, et al. Reducing tunneled catheter-related Infection in hemodialysis patients with nationwide standardization of catheter care protocol. J Vasc Access. 2018;19(1):110–1.CrossRefPubMed
17.
go back to reference Kan L-P, Lin J-C, Chiu S-K, Yeh Y-C, Lin T-Y, Yang Y-S, et al. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients. J Microbiol Immunol Infect. 2014;47(1):15–22.CrossRefPubMed Kan L-P, Lin J-C, Chiu S-K, Yeh Y-C, Lin T-Y, Yang Y-S, et al. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients. J Microbiol Immunol Infect. 2014;47(1):15–22.CrossRefPubMed
18.
go back to reference Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):82–9.CrossRef Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(Suppl 2):82–9.CrossRef
19.
go back to reference Marcos M, Soriano A, Iñurrieta A, Martínez JA, Romero A, Cobos N, et al. Changing epidemiology of central venous catheter-related bloodstream Infections: increasing prevalence of Gram-negative pathogens. J Antimicrob Chemother. 2011;66(9):2119–25.CrossRefPubMed Marcos M, Soriano A, Iñurrieta A, Martínez JA, Romero A, Cobos N, et al. Changing epidemiology of central venous catheter-related bloodstream Infections: increasing prevalence of Gram-negative pathogens. J Antimicrob Chemother. 2011;66(9):2119–25.CrossRefPubMed
20.
go back to reference Shimon O, Green H, Eliakim-Raz N, Rozen-Zvi B, Ben-Zvi H, Zohar I, et al. Gram-negative bloodstream Infections in hemodialysis patients: a retrospective study. Clin Nephrol. 2018;90(2):117–24.CrossRefPubMed Shimon O, Green H, Eliakim-Raz N, Rozen-Zvi B, Ben-Zvi H, Zohar I, et al. Gram-negative bloodstream Infections in hemodialysis patients: a retrospective study. Clin Nephrol. 2018;90(2):117–24.CrossRefPubMed
21.
go back to reference Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System. Overview of nosocomial Infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41(6):848–54.CrossRefPubMed Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System. Overview of nosocomial Infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41(6):848–54.CrossRefPubMed
22.
go back to reference El Khudari H, Ozen M, Kowalczyk B, Bassuner J, Almehmi A. Hemodialysis catheters: update on types, outcomes, designs and Complications. Semin Intervent Radiol. 2022;39(1):90–102.CrossRefPubMedPubMedCentral El Khudari H, Ozen M, Kowalczyk B, Bassuner J, Almehmi A. Hemodialysis catheters: update on types, outcomes, designs and Complications. Semin Intervent Radiol. 2022;39(1):90–102.CrossRefPubMedPubMedCentral
23.
go back to reference Soi V, Moore CL, Kumbar L, Yee J. Prevention of catheter-related bloodstream Infections in patients on hemodialysis: challenges and management strategies. Int J Nephrol Renovasc Dis. 2016;9:95–103.CrossRefPubMedPubMedCentral Soi V, Moore CL, Kumbar L, Yee J. Prevention of catheter-related bloodstream Infections in patients on hemodialysis: challenges and management strategies. Int J Nephrol Renovasc Dis. 2016;9:95–103.CrossRefPubMedPubMedCentral
24.
go back to reference Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant. 2002;17(10):1802–7.CrossRefPubMed Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant. 2002;17(10):1802–7.CrossRefPubMed
25.
go back to reference Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, et al. Decontamination strategies and bloodstream Infections with antibiotic-resistant microorganisms in ventilated patients: a Randomized Clinical Trial. JAMA. 2018;320(20):2087–98.CrossRefPubMedPubMedCentral Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, et al. Decontamination strategies and bloodstream Infections with antibiotic-resistant microorganisms in ventilated patients: a Randomized Clinical Trial. JAMA. 2018;320(20):2087–98.CrossRefPubMedPubMedCentral
26.
go back to reference Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant. 2004;19(5):1237–44.CrossRefPubMed Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant. 2004;19(5):1237–44.CrossRefPubMed
27.
go back to reference Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 2002;61(3):1136–42.CrossRefPubMed Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 2002;61(3):1136–42.CrossRefPubMed
28.
go back to reference Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int. 2000;57(5):2151–5.CrossRefPubMed Tanriover B, Carlton D, Saddekni S, Hamrick K, Oser R, Westfall AO, et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int. 2000;57(5):2151–5.CrossRefPubMed
29.
go back to reference Teehan GS, Bahdouch D, Ruthazer R, Balakrishnan VS, Snydman DR, Jaber BL. Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis. 2004;38(8):1090–4.CrossRefPubMed Teehan GS, Bahdouch D, Ruthazer R, Balakrishnan VS, Snydman DR, Jaber BL. Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy. Clin Infect Dis. 2004;38(8):1090–4.CrossRefPubMed
30.
go back to reference Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44(5):779–91.CrossRefPubMed Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44(5):779–91.CrossRefPubMed
31.
go back to reference Yamamoto T, Nakayama M, Miyazaki M, Sato H, Matsushima M, Sato T, et al. Impact of lower body mass index on risk of all-cause mortality and infection-related death in Japanese chronic Kidney Disease patients. BMC Nephrol. 2020;21(1):244.CrossRefPubMedPubMedCentral Yamamoto T, Nakayama M, Miyazaki M, Sato H, Matsushima M, Sato T, et al. Impact of lower body mass index on risk of all-cause mortality and infection-related death in Japanese chronic Kidney Disease patients. BMC Nephrol. 2020;21(1):244.CrossRefPubMedPubMedCentral
32.
go back to reference Hama EY, Uchiyama K, Nagasaka T, Kusahana E, Nakayama T, Yasuda I, et al. High body mass index is a risk factor for transition to hemodialysis or hybrid therapy and peritoneal dialysis-related Infection in Japanese patients undergoing peritoneal dialysis. Int Urol Nephrol. 2022;54(12):3193–202.CrossRefPubMed Hama EY, Uchiyama K, Nagasaka T, Kusahana E, Nakayama T, Yasuda I, et al. High body mass index is a risk factor for transition to hemodialysis or hybrid therapy and peritoneal dialysis-related Infection in Japanese patients undergoing peritoneal dialysis. Int Urol Nephrol. 2022;54(12):3193–202.CrossRefPubMed
33.
go back to reference Brown RS, Brickel K, Davis RB. Two-year observational study of bloodstream Infection rates in Hemodialysis Facility patients with and without catheters. Clin J Am Soc Nephrol. 2018;13(9):1381–8.CrossRefPubMedPubMedCentral Brown RS, Brickel K, Davis RB. Two-year observational study of bloodstream Infection rates in Hemodialysis Facility patients with and without catheters. Clin J Am Soc Nephrol. 2018;13(9):1381–8.CrossRefPubMedPubMedCentral
Metadata
Title
Blood stream Infections in chronic hemodialysis patients - characteristics and outcomes
Authors
Miri Schamroth Pravda
Yasmin Maor
Konstantin Brodsky
Anna Katkov
Relu Cernes
Nili Schamroth Pravda
Milena Tocut
Iris Zohar
Arie Soroksky
Leonid Feldman
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Antibiotic
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03442-5

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.